EQUILLIUM INC (EQ) Fundamental Analysis & Valuation

NASDAQ:EQ • US29446K1060

Current stock price

1.88 USD
-0.18 (-8.74%)
At close:
1.88 USD
0 (0%)
After Hours:

This EQ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. EQ Profitability Analysis

1.1 Basic Checks

  • EQ had negative earnings in the past year.
  • In the past year EQ has reported a negative cash flow from operations.
  • EQ had negative earnings in each of the past 5 years.
  • In the past 5 years EQ always reported negative operating cash flow.
EQ Yearly Net Income VS EBIT VS OCF VS FCFEQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • EQ has a worse Return On Assets (-70.76%) than 64.35% of its industry peers.
  • The Return On Equity of EQ (-78.92%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -70.76%
ROE -78.92%
ROIC N/A
ROA(3y)-45.84%
ROA(5y)-43.62%
ROE(3y)-98.95%
ROE(5y)-79.65%
ROIC(3y)N/A
ROIC(5y)N/A
EQ Yearly ROA, ROE, ROICEQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

  • EQ does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EQ Yearly Profit, Operating, Gross MarginsEQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. EQ Health Analysis

2.1 Basic Checks

  • EQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for EQ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
EQ Yearly Shares OutstandingEQ Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EQ Yearly Total Debt VS Total AssetsEQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • EQ has an Altman-Z score of 11.34. This indicates that EQ is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of EQ (11.34) is better than 83.24% of its industry peers.
  • EQ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.34
ROIC/WACCN/A
WACC9.37%
EQ Yearly LT Debt VS Equity VS FCFEQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • EQ has a Current Ratio of 10.85. This indicates that EQ is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 10.85, EQ belongs to the best of the industry, outperforming 83.62% of the companies in the same industry.
  • A Quick Ratio of 10.85 indicates that EQ has no problem at all paying its short term obligations.
  • The Quick ratio of EQ (10.85) is better than 83.62% of its industry peers.
Industry RankSector Rank
Current Ratio 10.85
Quick Ratio 10.85
EQ Yearly Current Assets VS Current LiabilitesEQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. EQ Growth Analysis

3.1 Past

  • EQ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -117.39%.
EPS 1Y (TTM)-117.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

  • EQ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.36% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y42.32%
EPS Next 2Y19.3%
EPS Next 3Y3.67%
EPS Next 5Y4.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EQ Yearly Revenue VS EstimatesEQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10M 20M 30M 40M
EQ Yearly EPS VS EstimatesEQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. EQ Valuation Analysis

4.1 Price/Earnings Ratio

  • EQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EQ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EQ Price Earnings VS Forward Price EarningsEQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EQ Per share dataEQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.3%
EPS Next 3Y3.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EQ Dividend Analysis

5.1 Amount

  • No dividends for EQ!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EQ Fundamentals: All Metrics, Ratios and Statistics

EQUILLIUM INC

NASDAQ:EQ (3/27/2026, 8:13:59 PM)

After market: 1.88 0 (0%)

1.88

-0.18 (-8.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-25
Earnings (Next)05-12
Inst Owners58.11%
Inst Owner Change24.74%
Ins Owners14.05%
Ins Owner Change-2.19%
Market Cap114.47M
Revenue(TTM)N/A
Net Income(TTM)-24.42M
Analysts85.45
Price Target5.61 (198.4%)
Short Float %4.33%
Short Ratio3.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)37.93%
Min EPS beat(2)16.03%
Max EPS beat(2)59.83%
EPS beat(4)4
Avg EPS beat(4)39.05%
Min EPS beat(4)16.03%
Max EPS beat(4)59.83%
EPS beat(8)8
Avg EPS beat(8)58.68%
EPS beat(12)12
Avg EPS beat(12)84.03%
EPS beat(16)13
Avg EPS beat(16)61.88%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)52%
EPS NY rev (1m)-4.65%
EPS NY rev (3m)39.19%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.06
P/FCF N/A
P/OCF N/A
P/B 3.7
P/tB 3.7
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0.07
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -70.76%
ROE -78.92%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.84%
ROA(5y)-43.62%
ROE(3y)-98.95%
ROE(5y)-79.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.92%
Cap/Sales 0.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.85
Quick Ratio 10.85
Altman-Z 11.34
F-Score3
WACC9.37%
ROIC/WACCN/A
Cap/Depr(3y)111.69%
Cap/Depr(5y)164.16%
Cap/Sales(3y)0.71%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y42.32%
EPS Next 2Y19.3%
EPS Next 3Y3.67%
EPS Next 5Y4.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-259.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-295.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-295%
OCF growth 3YN/A
OCF growth 5YN/A

EQUILLIUM INC / EQ Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EQUILLIUM INC?

ChartMill assigns a fundamental rating of 2 / 10 to EQ.


Can you provide the valuation status for EQUILLIUM INC?

ChartMill assigns a valuation rating of 0 / 10 to EQUILLIUM INC (EQ). This can be considered as Overvalued.


What is the profitability of EQ stock?

EQUILLIUM INC (EQ) has a profitability rating of 0 / 10.


What is the earnings growth outlook for EQUILLIUM INC?

The Earnings per Share (EPS) of EQUILLIUM INC (EQ) is expected to grow by 42.32% in the next year.